交易 Black Diamond Therapeutics, Inc. - BDTX CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.0672 | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Black Diamond Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Jun 5, 2023 | 2.4564 | 0.1998 | 8.85% | 2.2566 | 2.5063 | 2.2366 |
Jun 2, 2023 | 2.3266 | 0.1399 | 6.40% | 2.1867 | 2.3665 | 2.0969 |
Jun 1, 2023 | 2.1368 | 0.3295 | 18.23% | 1.8073 | 2.1668 | 1.7973 |
May 31, 2023 | 1.8373 | 0.0300 | 1.66% | 1.8073 | 1.8572 | 1.7973 |
May 30, 2023 | 1.8572 | 0.0999 | 5.68% | 1.7573 | 1.8772 | 1.7573 |
May 26, 2023 | 1.7673 | 0.0699 | 4.12% | 1.6974 | 1.7774 | 1.6575 |
May 25, 2023 | 1.7274 | 0.0699 | 4.22% | 1.6575 | 1.7574 | 1.6575 |
May 24, 2023 | 1.6974 | 0.0100 | 0.59% | 1.6874 | 1.7374 | 1.6375 |
May 23, 2023 | 1.6775 | -0.1298 | -7.18% | 1.8073 | 1.8672 | 1.6774 |
May 22, 2023 | 1.8373 | 0.0899 | 5.14% | 1.7474 | 1.8772 | 1.7474 |
May 19, 2023 | 1.7773 | 0.0699 | 4.09% | 1.7074 | 1.7873 | 1.6175 |
May 18, 2023 | 1.5976 | -0.0998 | -5.88% | 1.6974 | 1.6975 | 1.5576 |
May 17, 2023 | 1.7074 | -0.0400 | -2.29% | 1.7474 | 1.7674 | 1.6774 |
May 16, 2023 | 1.7673 | -0.1198 | -6.35% | 1.8871 | 1.9171 | 1.7673 |
May 15, 2023 | 1.9171 | 0.1198 | 6.67% | 1.7973 | 1.9271 | 1.7573 |
May 12, 2023 | 1.8672 | -0.0399 | -2.09% | 1.9071 | 1.9071 | 1.8073 |
May 11, 2023 | 1.9171 | 0.1098 | 6.08% | 1.8073 | 1.9970 | 1.7973 |
May 10, 2023 | 1.8472 | 0.0499 | 2.78% | 1.7973 | 1.8972 | 1.7973 |
May 9, 2023 | 1.8173 | 0.0400 | 2.25% | 1.7773 | 1.8173 | 1.6575 |
May 8, 2023 | 1.9072 | 0.0300 | 1.60% | 1.8772 | 1.9371 | 1.8572 |
Black Diamond Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Friday, June 9, 2023 | ||
时间(协调世界时) (UTC) 16:45 | 国家 US
| 事件 Black Diamond Therapeutics Inc at Jefferies Healthcare Conference Black Diamond Therapeutics Inc at Jefferies Healthcare ConferenceForecast -Previous - |
Monday, August 7, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家 US
| 事件 Q2 2023 Black Diamond Therapeutics Inc Earnings Release Q2 2023 Black Diamond Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
时间(协调世界时) (UTC) 13:30 | 国家 US
| 事件 Q3 2023 Black Diamond Therapeutics Inc Earnings Release Q3 2023 Black Diamond Therapeutics Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 92.828 | 126.872 | 69.57 | 29.332 | 8.904 |
銷售/一般/行政費用,總計 | 28.391 | 30.043 | 21.361 | 7.579 | 1.954 |
研究與開發 | 64.437 | 96.829 | 48.209 | 21.753 | 6.95 |
異常費用(收入) | 0 | ||||
營業收入 | -92.828 | -126.872 | -69.57 | -29.332 | -8.904 |
利息收入(費用),非經營淨值 | -0.219 | 3.464 | 4.041 | -5.932 | -0.011 |
其他,淨值 | -0.354 | -2.188 | -1.725 | 0.006 | -0.016 |
稅前淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
稅後淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
未計算非常項目前的淨收益 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
普通股股東可獲收益 (不含非經常性項目) | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
普通股股東可獲收益 (含非經常性項目) | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
攤薄淨收入 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
攤薄後加權平均股 | 36.3256 | 36.189 | 32.9071 | 32.6364 | 32.6364 |
扣除特別項目的每股攤薄盈利 | -2.50977 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -2.57122 | -3.47056 | -2.04375 | -1.08033 | -0.27365 |
Gain (Loss) on Sale of Assets | 2.232 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 21.561 | 21.852 | 22.124 | 23.173 | 25.679 |
銷售/一般/行政費用,總計 | 6.808 | 7.243 | 6.277 | 6.978 | 7.893 |
研究與開發 | 14.753 | 14.609 | 15.847 | 16.195 | 17.786 |
營業收入 | -21.561 | -21.852 | -22.124 | -23.173 | -25.679 |
利息收入(費用),非經營淨值 | 0.622 | -1.573 | 0.562 | 0.386 | 0.406 |
其他,淨值 | 0.064 | 0.115 | -0.092 | -0.143 | -0.234 |
稅前淨收入 | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
稅後淨收入 | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
未計算非常項目前的淨收益 | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
淨收入 | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
普通股股東可獲收益 (不含非經常性項目) | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
普通股股東可獲收益 (含非經常性項目) | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
攤薄淨收入 | -20.875 | -21.078 | -21.654 | -22.93 | -25.507 |
攤薄後加權平均股 | 36.4839 | 36.3902 | 36.3462 | 36.2939 | 36.2713 |
扣除特別項目的每股攤薄盈利 | -0.57217 | -0.57922 | -0.59577 | -0.63179 | -0.70323 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.57217 | -0.64056 | -0.59577 | -0.63179 | -0.70323 |
Gain (Loss) on Sale of Assets | 2.232 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 127.706 | 215.703 | 319.554 | 155.714 | 51.684 |
現金和短期投資 | 122.807 | 209.786 | 315.067 | 154.666 | 51.66 |
現金等價物 | 34.315 | 65.799 | 34.605 | 154.666 | 51.66 |
Prepaid Expenses | 4.899 | 5.917 | 4.487 | 1.048 | 0.024 |
Total Assets | 156.255 | 247.682 | 329.67 | 158.295 | 51.826 |
Property/Plant/Equipment, Total - Net | 27.381 | 30.74 | 8.787 | 0.164 | 0.134 |
Property/Plant/Equipment, Total - Gross | 28.131 | 31.109 | 8.951 | 0.276 | 0.234 |
Accumulated Depreciation, Total | -0.75 | -0.369 | -0.164 | -0.112 | -0.1 |
Other Long Term Assets, Total | 1.168 | 1.239 | 1.329 | 2.417 | 0.008 |
Total Current Liabilities | 15.261 | 23.642 | 14.218 | 4.863 | 2.575 |
Accounts Payable | 1.877 | 4.107 | 2.538 | 1.964 | 0.416 |
Accrued Expenses | 13.384 | 19.535 | 11.68 | 2.899 | 0.452 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 1.707 | |||
Total Liabilities | 40.56 | 51.782 | 21.912 | 4.879 | 6.598 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 25.299 | 28.14 | 7.694 | 0.016 | 4.023 |
Total Equity | 115.695 | 195.9 | 307.758 | 153.416 | 45.228 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 60.77 | ||
Common Stock | 0.005 | 0.005 | 0.005 | 0.001 | 0.001 |
Additional Paid-In Capital | 452.503 | 440.129 | 425.363 | 3.812 | 0.169 |
Retained Earnings (Accumulated Deficit) | -334.989 | -243.82 | -118.224 | -50.97 | -15.712 |
Total Liabilities & Shareholders’ Equity | 156.255 | 247.682 | 329.67 | 158.295 | 51.826 |
Total Common Shares Outstanding | 36.4343 | 36.2346 | 36.0784 | 32.6364 | 32.6364 |
Redeemable Preferred Stock | 0 | 0 | 200.573 | ||
短期投資 | 88.492 | 143.987 | 280.462 | ||
Other Equity, Total | -0.414 | 0.614 | |||
Unrealized Gain (Loss) | -1.824 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 107.977 | 127.706 | 150.978 | 168.558 | 188.304 |
現金和短期投資 | 103.366 | 122.807 | 144.181 | 160.89 | 179.739 |
現金等價物 | 39.141 | 34.315 | 53.96 | 55.877 | 54.081 |
短期投資 | 64.225 | 88.492 | 90.221 | 105.013 | 125.658 |
Prepaid Expenses | 4.611 | 4.899 | 6.797 | 7.668 | 8.565 |
Total Assets | 135.582 | 156.255 | 180.416 | 198.834 | 219.482 |
Property/Plant/Equipment, Total - Net | 26.437 | 27.381 | 28.27 | 29.098 | 29.945 |
Property/Plant/Equipment, Total - Gross | 27.282 | 28.131 | 28.98 | 29.681 | 30.439 |
Accumulated Depreciation, Total | -0.845 | -0.75 | -0.71 | -0.583 | -0.494 |
Other Long Term Assets, Total | 1.168 | 1.168 | 1.168 | 1.178 | 1.233 |
Total Current Liabilities | 12.847 | 15.261 | 21.143 | 19.706 | 19.469 |
Accounts Payable | 3.046 | 1.877 | 5.76 | 2.222 | 1.883 |
Accrued Expenses | 9.801 | 13.384 | 15.383 | 17.484 | 17.586 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 37.392 | 40.56 | 47.185 | 46.463 | 46.922 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 24.545 | 25.299 | 26.042 | 26.757 | 27.453 |
Total Equity | 98.19 | 115.695 | 133.231 | 152.371 | 172.56 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
Additional Paid-In Capital | 455.225 | 452.503 | 449.625 | 446.909 | 443.657 |
Retained Earnings (Accumulated Deficit) | -355.864 | -334.989 | -313.911 | -292.257 | -269.327 |
Other Equity, Total | -1.176 | -1.824 | -2.488 | -2.286 | -1.775 |
Total Liabilities & Shareholders’ Equity | 135.582 | 156.255 | 180.416 | 198.834 | 219.482 |
Total Common Shares Outstanding | 36.512 | 36.4343 | 36.3662 | 36.3157 | 36.2876 |
Redeemable Preferred Stock |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -91.169 | -125.596 | -67.254 | -35.258 | -8.931 |
經營活動産生的現金 | -85.082 | -100.148 | -52.146 | -24.674 | -8.454 |
經營活動産生的現金 | 0.508 | 0.205 | 0.052 | 0.047 | 0.044 |
非現金物品 | 15.48 | 18.223 | 10.014 | 10.074 | 0.079 |
營運資金的變化 | -9.901 | 7.02 | 5.042 | 0.463 | 0.354 |
投資活動産生的現金 | 53.366 | 130.613 | -281.691 | -0.021 | -0.076 |
資本支出 | -0.192 | -2.71 | -0.142 | -0.021 | -0.076 |
其他投資現金流量項目,總計 | 53.558 | 133.323 | -281.549 | 0 | |
融資活動産生的現金 | 0.177 | 0.729 | 214.944 | 127.756 | 52.312 |
融資現金流項目 | 0 | -1.743 | 0 | ||
股票的發行(報廢),淨額 | 0.177 | 0.729 | 214.944 | 129.499 | 52.312 |
債務的發行(退還),淨額 | 0 | ||||
現金淨變化 | -31.539 | 31.194 | -118.893 | 103.061 | 43.782 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -20.875 | -91.169 | -70.091 | -48.437 | -25.507 |
Cash From Operating Activities | -20.031 | -85.082 | -63.143 | -46.667 | -28.6 |
Cash From Operating Activities | 0.122 | 0.508 | 0.382 | 0.253 | 0.125 |
Non-Cash Items | 3.507 | 15.48 | 11.804 | 8.366 | 4.293 |
Changes in Working Capital | -2.785 | -9.901 | -5.238 | -6.849 | -7.511 |
Cash From Investing Activities | 24.806 | 53.366 | 51.044 | 36.537 | 16.729 |
Capital Expenditures | 0 | -0.192 | -0.192 | -0.2 | -0.007 |
Other Investing Cash Flow Items, Total | 24.806 | 53.558 | 51.236 | 36.737 | 16.736 |
Cash From Financing Activities | 0.051 | 0.177 | 0.205 | 0.153 | 0.153 |
Issuance (Retirement) of Stock, Net | 0.051 | 0.177 | 0.205 | 0.153 | 0.153 |
Net Change in Cash | 4.826 | -31.539 | -11.894 | -9.977 | -11.718 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Versant Ventures | Venture Capital | 17.6634 | 6449348 | 0 | 2023-03-15 | LOW |
Bellevue Asset Management AG | Investment Advisor | 14.778 | 5395839 | -5000 | 2023-03-31 | LOW |
New Enterprise Associates (NEA) | Venture Capital | 9.4454 | 3448757 | 0 | 2023-03-31 | LOW |
RA Capital Management, LP | Hedge Fund | 7.0932 | 2589904 | 0 | 2023-03-31 | LOW |
Boxer Capital, L.L.C. | Hedge Fund | 5.5183 | 2014858 | 0 | 2023-03-31 | LOW |
Invus Public Equities Advisors, LLC | Investment Advisor | 4.5095 | 1646517 | 0 | 2023-03-31 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 3.2621 | 1191094 | 908963 | 2023-03-31 | LOW |
Epstein (David M) | Individual Investor | 2.5703 | 938479 | 0 | 2023-03-15 | LOW |
Millennium Management LLC | Hedge Fund | 2.1269 | 776594 | 252037 | 2023-03-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.0749 | 757585 | 0 | 2023-03-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 1.5276 | 557771 | -216027 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4344 | 523719 | -127676 | 2023-03-31 | LOW |
Verition Fund Management LLC | Hedge Fund | 0.943 | 344307 | 344307 | 2023-03-31 | HIGH |
Newtyn Management, LLC | Hedge Fund | 0.8397 | 306609 | -8391 | 2023-03-31 | MED |
Two Sigma Investments, LP | Hedge Fund | 0.7769 | 283654 | -72510 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7406 | 270428 | 5138 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.5957 | 217500 | -3113 | 2023-03-31 | HIGH |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.5023 | 183398 | -102283 | 2023-03-31 | LOW |
BioImpact Capital LLC | Investment Advisor/Hedge Fund | 0.3968 | 144888 | 0 | 2023-03-31 | LOW |
Tekla Capital Management LLC | Investment Advisor | 0.3615 | 131990 | 0 | 2023-03-31 | LOW |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
One Main Street, 14th Floor
CAMBRIDGE
MASSACHUSETTS 02142
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 535.000 多名交易者,選擇與 Capital.com 交易